Evotec Se 6-K Filing
Ticker: EVOTF · Form: 6-K · Filed: Dec 8, 2025 · CIK: 1412558
| Field | Detail |
|---|---|
| Company | Evotec Se (EVOTF) |
| Form Type | 6-K |
| Filed Date | Dec 8, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Evotec Se (ticker: EVOTF) to the SEC on Dec 8, 2025.
How long is this filing?
Evotec Se's 6-K filing is 1 pages with approximately 211 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 211 words · 1 min read · ~1 pages · Grade level 16.7 · Accepted 2025-12-08 07:00:12
Filing Documents
- tm2532947d1_6k.htm (6-K) — 8KB
- tm2532947d1_ex99-1.htm (EX-99.1) — 14KB
- tm2532947d1_ex99-1img01.jpg (GRAPHIC) — 20KB
- tm2532947d1_ex99-1img02.jpg (GRAPHIC) — 12KB
- 0001104659-25-119055.txt ( ) — 68KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of December, 2025 COMMISSION FILE NUMBER 001-34041 Evotec SE (Translation of registrant’s name into English) Essener Bogen 7 22419 Hamburg Germany Tel: +49 40 560810 (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F: Form 20-F Form 40-F Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): On December 08, 2025, Evotec SE (the “Company”) issued a press release announcing closing of agreement with Sandoz attached as Exhibit 99.1 hereto. EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Evotec closes sale of Just – Evotec Biologics’ Toulouse site to Sandoz SIGNATURE Pursuant to the requirements, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Evotec SE By: /s/ Christian Wojczewski Name: Christian Wojczewski Title: Chief Executive Officer Date: December 08, 2025